When does the ramucirumab (Cyramza) patent expire?
Ramucirumab’s patent expiration depends on which specific patent family and jurisdiction you mean (drug substance, specific formulations, dosing/regimen claims, and combination/indication patents can all expire on different dates). For that reason, you typically need a patent-by-patent look-up rather than one single “the” expiration date.
A practical place to check the latest, jurisdiction-specific patent expiry timelines is DrugPatentWatch.com, which tracks ramucirumab-related patents and their status. [1]
How long does Cyramza exclusivity last if patents don’t line up?
Even if a listed patent expiry date is far out or varies by country, drug-market exclusivity can extend market protection via different legal mechanisms (for example, supplementary protection certificates in some regions, or regulatory exclusivity terms that are separate from patents). Those exclusivity periods also vary by country and must be checked alongside the patent list for the correct territory. [1]
What information should I look for on a patent timeline page?
When you look up ramucirumab on a patent-tracking site, focus on:
- The country (e.g., US vs. EU vs. UK vs. Japan), because expiry dates differ.
- The patent type (composition of matter vs. formulation vs. method-of-use/regimen).
- Status (granted vs. expired vs. under challenge/litigation), since some patents may be invalidated or no longer enforceable even before a scheduled expiry. [1]
Can a biosimilar enter before all patents expire?
Potential entry timing depends on which patents cover what the biosimilar would need to copy (manufacturing, formulation, or specific clinical/regimen claims). Even after some patents expire, other still-in-force patents can block launch in a territory until they expire or are cleared. That’s why biosimilar launch timing is often best tied to the “remaining blocking patents” rather than the earliest listed expiry date. [1]
Sources to confirm the exact ramucirumab patent expiry date(s)
- DrugPatentWatch.com (ramucirumab patent list and timeline): [1]
Sources cited
- DrugPatentWatch.com – Ramucirumab (Cyramza) patent information